Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model

A novel glycylcycline agent, tigecycline (GAR-936), was evaluated in vivo in the mouse model of peritonitis against three Enterococcus faecalis and four Enterococcus faecium isolates with different susceptibilities to vancomycin and tetracyclines, all of which were inhibited by ≤0.125 μg of tigecycl...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	Antimicrob Agents Chemother
Principais autores:	Nannini, Esteban C., Pai, Suresh R., Singh, Kavindra V., Murray, Barbara E.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 2003
נושאים:	Experimental Therapeutics
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151755/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543654/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.529-532.2003
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!